Neiratax

Thiamine Hydrochloride, Cyanocobalamin, Pyridoxine Hydrochloride and Lidocaine Hydrochloride, the active ingredients in Neiratax, are a vitamin B complex combined with a local anesthetic presented as an injectable for intramuscular use. It is employed to correct vitamin deficiencies and to provide local anesthesia in clinical settings.

GNH USA supplies Neiratax as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Neiratax combines vitamins and a local anesthetic, addressing nutritional deficiencies and providing short‑term anesthesia. - Vitamin B1 deficiency: restores thiamine levels and supports carbohydrate metabolism. - Vitamin B12 deficiency: replenishes cyanocobalamin for red blood cell formation and neurological health. - Vitamin B6 deficiency: supplies pyridoxine for amino‑acid metabolism and neurotransmitter synthesis. - Minor surgical or diagnostic procedures: provides local anesthesia through lidocaine to reduce pain.

Neiratax may cause a range of adverse reactions.

Common Side Effects: - Injection site pain: mild to moderate discomfort at the site. - Nausea: transient feeling of queasiness. - Headache: mild headache following administration. - Dizziness: temporary light‑headedness. - Local irritation: redness or swelling. - Transient numbness: temporary loss of sensation.

Serious or Rare Side Effects: - Anaphylactic reaction: severe allergy requiring immediate medical attention. - Cardiovascular instability: hypotension or arrhythmia. - Seizures: rare central nervous system excitation. - Stevens‑Johnson syndrome: severe skin reaction. - Respiratory depression: difficulty breathing. - Persistent neurological deficits: prolonged numbness or weakness.

Before using Neiratax, consider the following safety measures. - Assess vitamin status: evaluate patient’s B‑vitamin levels prior to therapy. - Monitor hypersensitivity: observe for signs of allergic reaction during and after injection. - Cardiac caution: use carefully in patients with conduction disorders or arrhythmias. - Lidocaine allergy: avoid in individuals with known hypersensitivity to amide‑type local anesthetics. - Renal/hepatic impairment: adjust use in patients with significant organ dysfunction. - Store at ambient temperature: keep in original container, protect from moisture and light.

Neiratax may interact with other medicines.

Major Interactions (Avoid): - Other local anesthetics: combined use can increase systemic toxicity. - MAO inhibitors: concurrent use may potentiate cardiovascular effects of lidocaine. - High‑dose vitamin B supplements: risk of hypervitaminosis.

Moderate Interactions (Monitor Closely): - Anticoagulants: monitor bleeding risk due to injection trauma. - Anticonvulsants: observe for additive CNS effects. - Beta‑blockers: may enhance bradycardic effects of lidocaine.